All premenopausal women who had been treated with goserelin and anastrozole for advanced breast cancer in the Nottingham Breast Unit were included in the study. A total of 16 such patients with a ...

Based on the above rationale, a clinical trial assessing the efficacy and tolerability of the antiestrogen tamoxifen (‘Nolvadex’) 20 mg and the aromatase inhibitor anastrozole (‘Arimidex ...

To the Editor: Mehta et al. (Aug. 2 issue) 1 report that the combination of anastrozole and fulvestrant was superior to anastrozole alone when administered as first-line endocrine therapy to North ...

RESULTS: Patients were followed for a median period of 14.4 months. In terms of TTP, fulvestrant was as effective as anastrozole (hazard ratio, 0.98; confidence interval [CI], 0.80 to 1.21; P = .84).

RESULTS: Anastrozole was as effective as tamoxifen in terms of OR (21% v 17% of patients, respectively), with clinical benefit (CR + PR + stabilization ≥ 24 weeks) observed in 59% of patients on ...

Anastrozole, a daily pill to prevent breast cancer, will now be available to thousands of more women in the UK after being cleared for wider use.. The drug has been used to treat hormone-driven ...

Anastrozole provides a significant benefit compared with tamoxifen in preventing recurrence after a lumpectomy and radiation therapy in postmenopausal women ages 60 years or younger who had DCIS ...

Anastrozole is a drug used to both treat and prevent hormone-driven breast cancers. It works by reducing the amount of estrogen the body can make by blocking an enzyme called aromatase.

Tens of thousands of women in England could benefit from a drug that helps prevent breast cancer. Anastrozole, used for many years to treat the disease, has now been licensed as a preventative ...

ALMOST 300,000 women at high risk of breast cancer are to be offered a 4p pill on the NHS that could halve the danger. Once-a-day tumour drug Anastrozole is to be repurposed as a preventative after… ...